First Manhattan’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-272
Closed -$10K 1499
2020
Q1
$10K Buy
+272
New +$15.9K ﹤0.01% 1144
2019
Q2
Sell
-2,000
Closed -$103K 1464
2019
Q1
$103K Hold
2,000
﹤0.01% 823
2018
Q4
$78K Hold
2,000
﹤0.01% 841
2018
Q3
$103K Buy
+2,000
New +$97.9K ﹤0.01% 842

Other funds holding SYNH

First Manhattan's SYNH Position: Q2 2020 in Review

First Manhattan sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2020, closing a stake of 272 shares — an estimated $10K sold.

First Manhattan first reported a position in SYNH in Q3 2018 and held it in 4 quarters. The position peaked at $103K in Q1 2019. 285 funds tracked by Wall St. Rank hold SYNH as of Q2 2020.

  • First Manhattan reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2020 after selling out during the quarter.
  • First Manhattan sold 272 Syneos Health, Inc. Class A Common Stock shares in Q2 2020, an estimated $10K.
  • First Manhattan first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2018 and held it in 4 quarters.
  • First Manhattan's Syneos Health, Inc. Class A Common Stock position peaked at $103K in Q1 2019.
  • 285 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2020.

Based on First Manhattan's 13F filing for Q2 2020, filed 14 Aug 2020.